Skip to main content
Premium Trial:

Request an Annual Quote

Roche Acquires NGS Target-Enrichment Tech from AbVitro

NEW YORK (GenomeWeb) – Roche said today that it has acquired the exclusive rights to next-generation sequencing target enrichment technology from AbVitro, a company focused on therapeutic target discovery.

Under the terms of the agreement, the two companies will collaborate to develop the technology, called primer extension-based target enrichment (PETE). Roche plans to use PETE to support next-generation sequencing directly from blood or other biological samples. In addition, Roche will incorporate the PETE technology into the Roche Sequencing Unit R&D pipeline to support its clinical sequencing strategy.

"The potential of this technology will allow Roche to optimize our sequencing portfolio to provide a full workflow solution for our customers," Dan Zabrowski, head of Roche Tissue Diagnostics and the Sequencing Unit, said in a statement. "We look forward to advancing this technology in order to streamline sequencing methods for easy-to-use clinical applications."

Francois Vigneault, president, CSO and co-founder of AbVitro, added in a statement that the technology "surpasses current industry standards and we believe Roche to be incredibly well positioned to create a true disruption in the next-generation sample prep market."

AbVitro is developing single-cell immune sequencing technology based on work by co-founder George Church of Harvard Medical School. According to the company, the platform enables the identification of complete natively paired B-cell antibodies and T-cell receptors across millions of single cells and can then be used to identify novel therapeutic targets and antibodies to cancer and autoimmune diseases.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.